Publicaciones en colaboración con investigadores/as de Instituto de Salud Carlos III (2)

2022

  1. Essential Topics for the Regulatory Consideration of Phages as Clinically Valuable Therapeutic Agents: A Perspective from Spain

    Microorganisms, Vol. 10, Núm. 4

  2. The role of PemIK (PemK/PemI) type II TA system from Klebsiella pneumoniae clinical strains in lytic phage infection

    Scientific Reports, Vol. 12, Núm. 1